AlumierMD appoints Dr Tom Kamal as a KOL
Skincare company AlumierMD has announced aesthetic practitioner Dr Tom Kamal as a UK key opinion leader (KOL). AlumierMD shares that Dr Kamal will work closely with the professional skincare brand
Skincare company AlumierMD has announced aesthetic practitioner Dr Tom Kamal as a UK key opinion leader (KOL). AlumierMD shares that Dr Kamal will work closely with the professional skincare brand
The Joint Council for Cosmetic Practitioners (JCCP) has published new guidance for platelet-rich plasma (PRP) procedures within medical aesthetic settings. This guidance was developed by a panel of health protection
Medical device company Dermalux has introduced Rachel Hand as a new territory business manager for Ireland. Following her previous role with skincare company AlumierMD as business growth partner and account
The British College of Aesthetic Medicine (BCAM) has announced aesthetic practitioner Dr Rebecca Norman as its latest vice president. The organisation shares that Dr Norman will support the president and
Aesthetic distributor Healthxchange has announced its exclusive distribution of the Potenza radiofrequency (RF) microneedling system in the UK and Ireland. According to the company, the Potenza system combines monopolar and
Pharmaceutical company IBSA Derma, the UK and Ireland subsidiary of global pharmaceutical leader IBSA, has announced that it will assume responsibility for the distribution of injectables Profhilo, Aliaxin and Viscoderm.
Aesthetic distributor DermaFocus has introduced three new key opinion leaders (KOLs) along with the promotion of aesthetic practitioner Dr Kam Lally. The first KOL announced is Dr Ed Robinson, an
For the first time at the Clinical Cosmetic Regenerative Conference (CCR), world-renowned nurse practitioner and lip augmentation expert Julie Horne will lead a two-hour symposium. In this keynote session on
Aesthetic distribution company Healthxchange has been announced as an authorised training provider for the Profhilo product range. The collaboration, confirmed by Profhilo’s exclusive distributor HA-Derma, comes ahead of the launch
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Allergan Aesthetics’ Botox (onabotulinumtoxinA) to treat platysma bands. The MHRA approval allows for the temporary improvement in the appearance